|
Mahamaya Lifesciences Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
280.39 Cr.
|
P/BV
|
4.74
|
Book Value (Rs.)
|
25.27
|
|
52 Week High/Low (Rs.)
|
122/111
|
FV/ML
|
10/1200
|
P/E(X)
|
21.66
|
|
Bookclosure
|
|
EPS (Rs.)
|
5.53
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 17.36 | 7.12 | 5.10 |
| | | | |
| Net CashFlow From Operating Activities | 0.52 | -22.66 | 1.07 |
| Net Cash Used In Investing Activities | -8.28 | -2.00 | -2.79 |
| Net Cash Used From Financing Activities | 8.52 | 24.35 | 2.35 |
| | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.77 | -0.31 | 0.63 |
| Cash And Cash Equivalents Begin of Year | 1.09 | 1.40 | 0.77 |
| Cash And Cash Equivalents End Of Year | 1.85 | 1.09 | 1.40 |